Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125433881 | 12543388 | 1 | I | 201507 | 20150805 | 20160711 | 20160711 | PER | US-TEVA-584774USA | TEVA | 67.24 | YR | F | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125433881 | 12543388 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MILLIGRAM DAILY; | 76565 | 75 | MG | CAPSULE | QD | ||||||
| 125433881 | 12543388 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 76565 | ||||||||||||
| 125433881 | 12543388 | 3 | SS | HYDROCHLOROTHIAZIDE W/LOSARTAN | HYDROCHLOROTHIAZIDELOSARTAN | 1 | Unknown | 100-25MG | 77157 | QD | |||||||||
| 125433881 | 12543388 | 4 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MILLIGRAM DAILY; | U | L11950 | 0 | 75 | MG | CAPSULE | QD | ||||
| 125433881 | 12543388 | 5 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | U | L11950 | 0 | ||||||||||
| 125433881 | 12543388 | 6 | C | CALCIUM 600 + D | CALCIUMVITAMIN D | 1 | 0 | QD | |||||||||||
| 125433881 | 12543388 | 7 | C | LIVALO | PITAVASTATIN CALCIUM | 1 | .5714 MILLIGRAM DAILY; | 0 | 4 | MG | /wk | ||||||||
| 125433881 | 12543388 | 8 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 4000 IU (INTERNATIONAL UNIT) DAILY; | 0 | 2000 | IU | |||||||||
| 125433881 | 12543388 | 9 | C | LOW DOSE ASPIRIN | ASPIRIN | 1 | 0 | BID | |||||||||||
| 125433881 | 12543388 | 10 | C | MELOXICAM. | MELOXICAM | 1 | 15 MILLIGRAM DAILY; | 0 | 15 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125433881 | 12543388 | 1 | Depression |
| 125433881 | 12543388 | 2 | Anxiety |
| 125433881 | 12543388 | 3 | Blood pressure measurement |
| 125433881 | 12543388 | 4 | Depression |
| 125433881 | 12543388 | 5 | Anxiety |
| 125433881 | 12543388 | 7 | Blood cholesterol increased |
| 125433881 | 12543388 | 8 | Vitamin D decreased |
| 125433881 | 12543388 | 10 | Arthropathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125433881 | 12543388 | Anxiety | |
| 125433881 | 12543388 | Asthenia | |
| 125433881 | 12543388 | Depression | |
| 125433881 | 12543388 | Hypotension | |
| 125433881 | 12543388 | Intentional product misuse | |
| 125433881 | 12543388 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125433881 | 12543388 | 1 | 201505 | 0 |